Morgan Stanley’s Seres Therapeutics MCRB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $87.1K | Buy |
7,838
+358
| +5% | +$3.98K | ﹤0.01% | 6183 |
|
|
2025
Q1 | $105K | Sell |
7,480
-93,183
| -93% | -$1.3M | ﹤0.01% | 5989 |
|
|
2024
Q4 | $1.67M | Buy |
100,663
+60,547
| +151% | +$1.01M | ﹤0.01% | 4826 |
|
|
2024
Q3 | $759K | Buy |
40,116
+31,562
| +369% | +$597K | ﹤0.01% | 5200 |
|
|
2024
Q2 | $124K | Sell |
8,554
-15,327
| -64% | -$222K | ﹤0.01% | 5884 |
|
|
2024
Q1 | $370K | Sell |
23,881
-64,653
| -73% | -$1M | ﹤0.01% | 5449 |
|
|
2023
Q4 | $2.48M | Buy |
88,534
+70,064
| +379% | +$1.96M | ﹤0.01% | 4805 |
|
|
2023
Q3 | $879K | Sell |
18,470
-4,589
| -20% | -$218K | ﹤0.01% | 4872 |
|
|
2023
Q2 | $2.21M | Buy |
23,059
+13,348
| +137% | +$1.28M | ﹤0.01% | 4367 |
|
|
2023
Q1 | $1.1M | Sell |
9,711
-1,235
| -11% | -$140K | ﹤0.01% | 4804 |
|
|
2022
Q4 | $1.23M | Buy |
10,946
+4,977
| +83% | +$557K | ﹤0.01% | 4747 |
|
|
2022
Q3 | $765K | Sell |
5,969
-5,263
| -47% | -$675K | ﹤0.01% | 5041 |
|
|
2022
Q2 | $770K | Sell |
11,232
-18,544
| -62% | -$1.27M | ﹤0.01% | 5187 |
|
|
2022
Q1 | $4.24M | Buy |
29,776
+2,540
| +9% | +$362K | ﹤0.01% | 3858 |
|
|
2021
Q4 | $4.54M | Sell |
27,236
-6,836
| -20% | -$1.14M | ﹤0.01% | 3820 |
|
|
2021
Q3 | $4.74M | Buy |
34,072
+2,679
| +9% | +$373K | ﹤0.01% | 3779 |
|
|
2021
Q2 | $15M | Buy |
31,393
+13,705
| +77% | +$6.54M | ﹤0.01% | 2506 |
|
|
2021
Q1 | $7.28M | Buy |
17,688
+10,133
| +134% | +$4.17M | ﹤0.01% | 3004 |
|
|
2020
Q4 | $3.7M | Buy |
7,555
+2,678
| +55% | +$1.31M | ﹤0.01% | 3587 |
|
|
2020
Q3 | $2.76M | Sell |
4,877
-166
| -3% | -$94K | ﹤0.01% | 3353 |
|
|
2020
Q2 | $480K | Buy |
5,043
+168
| +3% | +$16K | ﹤0.01% | 4623 |
|
|
2020
Q1 | $348K | Sell |
4,875
-2,319
| -32% | -$166K | ﹤0.01% | 4585 |
|
|
2019
Q4 | $496K | Buy |
7,194
+1,296
| +22% | +$89.4K | ﹤0.01% | 4925 |
|
|
2019
Q3 | $473K | Sell |
5,898
-1,247
| -17% | -$100K | ﹤0.01% | 4704 |
|
|
2019
Q2 | $460K | Sell |
7,145
-6,472
| -48% | -$417K | ﹤0.01% | 4648 |
|
|
2019
Q1 | $1.87M | Buy |
13,617
+4,986
| +58% | +$685K | ﹤0.01% | 3646 |
|
|
2018
Q4 | $780K | Sell |
8,631
-148
| -2% | -$13.4K | ﹤0.01% | 4472 |
|
|
2018
Q3 | $1.33M | Buy |
8,779
+468
| +6% | +$71.1K | ﹤0.01% | 4313 |
|
|
2018
Q2 | $1.43M | Sell |
8,311
-1,642
| -16% | -$283K | ﹤0.01% | 4370 |
|
|
2018
Q1 | $1.46M | Buy |
9,953
+4,522
| +83% | +$664K | ﹤0.01% | 4268 |
|
|
2017
Q4 | $1.1M | Buy |
5,431
+2,929
| +117% | +$594K | ﹤0.01% | 4475 |
|
|
2017
Q3 | $802K | Buy |
2,502
+1,127
| +82% | +$361K | ﹤0.01% | 4570 |
|
|
2017
Q2 | $311K | Sell |
1,375
-868
| -39% | -$196K | ﹤0.01% | 5089 |
|
|
2017
Q1 | $506K | Sell |
2,243
-2,398
| -52% | -$541K | ﹤0.01% | 4829 |
|
|
2016
Q4 | $919K | Buy |
4,641
+1,450
| +45% | +$287K | ﹤0.01% | 4532 |
|
|
2016
Q3 | $784K | Buy |
3,191
+1,430
| +81% | +$351K | ﹤0.01% | 4218 |
|
|
2016
Q2 | $1.02M | Sell |
1,761
-540
| -23% | -$314K | ﹤0.01% | 3952 |
|
|
2016
Q1 | $1.22M | Buy |
2,301
+613
| +36% | +$325K | ﹤0.01% | 3764 |
|
|
2015
Q4 | $1.19M | Buy |
1,688
+1,169
| +225% | +$821K | ﹤0.01% | 3933 |
|
|
2015
Q3 | $307K | Buy |
519
+394
| +315% | +$233K | ﹤0.01% | 4875 |
|
|
2015
Q2 | $104K | Buy |
+125
| New | +$104K | ﹤0.01% | 5563 |
|